Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation
Organ transplantation involving aged donors is often confounded by reduced post-transplantation organ survival. By studying both human organs and mouse transplantation models, here the authors show that pretreating the donors with senolytics to reduce mitochondria DNA and pro-inflammatory dendritic...
Main Authors: | Jasper Iske, Midas Seyda, Timm Heinbokel, Ryoichi Maenosono, Koichiro Minami, Yeqi Nian, Markus Quante, Christine S. Falk, Haruhito Azuma, Friederike Martin, João F. Passos, Claus U. Niemann, Tamara Tchkonia, James L. Kirkland, Abdallah Elkhal, Stefan G. Tullius |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-08-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-18039-x |
Similar Items
-
Restored TDCA and valine levels imitate the effects of bariatric surgery
by: Markus Quante, et al.
Published: (2021-06-01) -
Identification of HSP90 inhibitors as a novel class of senolytics
by: Heike Fuhrmann-Stroissnigg, et al.
Published: (2017-09-01) -
Targeting anxiety and senescence with senolytics
by: Raffaele, M., et al.
Published: (2022) -
Senolytics and senostatics as adjuvant tumour therapy
by: Susan Short, et al.
Published: (2019-03-01) -
Senolytics as drugs or fashionable dietary supplements
by: Małgorzata Starek, et al.
Published: (2021-05-01)